Company news

NeOnc Technologies Holdings, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

NeOnc Technologies Holdings Reports Third Quarter 2025 Results and Provides Operational Update

November 14, 2025

NeOnc Technologies Completes Enrollment in Pivotal NEO100 Phase2a Trial for IDH-1 mutant Recurrent High‑Grade Glioma and Expects Interim Data Readout in SixMonths (Q22026)

November 13, 2025

NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program

November 7, 2025

NeOnc Technologies Appoints Amir Heshmatpour as Chief Executive Officer to Drive Next Phase of Clinical and Corporate Growth

November 4, 2025

His Highness Sheikh Nahyan bin Zayed Al Nahyan Assumes Executive Chairmanship of NeOnc Technologies' Subsidiary, NuroMENA, Pioneering UAE-US Partnership in Brain Cancer Treatment

October 28, 2025

Meet the Companies - New to The Street's Accredited Investor Event Returns October 21-22 at Hudson Yards, NYC

October 10, 2025

NeOnc Technologies' Subsidiary, NuroMENA, Signs Master Services Agreement with M42’s IROS and Expands Board of Directors

October 9, 2025

NeOnc Technologies and Quazar Investment Set to Close $50 Million Strategic Partnership by October 23rd Following Final UAE Tax Approvals

October 6, 2025

NeOnc Technologies Appoints Dr. David M. Ashley, Director of The Preston Robert Tisch Brain Tumor Center at Duke, to Scientific Advisory Board

October 2, 2025

NeOnc Technologies Welcomes Dr. Alexandra M. Miller, Chief of Neuro-Oncology and Co-Director of the Brain and Spine Tumor Center at NYU Langone Health’s Perlmutter Cancer Center, to Its Scientific Advisory Board

October 1, 2025

NeOnc Technologies Appoints Renowned Neuro-Oncologist Dr. Henry S. Friedman to Scientific Advisory Board

September 29, 2025

NeOnc Technologies to Showcase Progress on Addressing Brain Cancer to 63 Million TV Households on “Health Uncensored with Dr. Drew” on the Lifetime Network on September 25, premiering nationwide at 8: 00 a.m. ET/PT

September 22, 2025

NeOnc Technologies Receives FDA Authorization to Proceed with Phase II Clinical Trial of NEO212 – A First-in-Class Oral Chemical Conjugated Chemotherapy Candidate for Brain Cancer

September 10, 2025

TexPower Appoints Bader Almonawer as President to Lead U.S. Lithium-Ion Battery Manufacturing Into the Future

September 4, 2025

NeOnc Technologies Closes Strategic Acquisition of Advanced AI and 3D Bioprinting IP, Appointing World-Renowned Scientist Dr. Ishwar K. Puri to its Board

August 25, 2025

NeOnc Technologies Holdings Reports Second Quarter 2025 Results and Provides Operational Update

August 19, 2025

New to The Street's Esteemed Client NeOnc Technologies Finalizes $50 Million Strategic Partnership with Quazar Investment as NuroMENA Holdings Receives ADGM Incorporation

August 11, 2025

NeOnc Technologies Finalizes All Contingencies for $50 Million Strategic Partnership with Quazar Investment as NuroMENA Holdings Receives ADGM Incorporation

August 11, 2025

NeOnc Technologies Awarded $2.5 Million in NIH STTR Grants to Advance NEO212 in Gliomas and Leukemia

August 7, 2025

NeOnc Technologies Featured on Yahoo Finance's Podcast Trader Talk: AI and Biotech Take on Brain Cancer

August 4, 2025

New to The Street Signs NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) to 12-Part National Broadcast Series Including T.V. Network Features, Earned Media, Commercials, and Iconic Outdoor Billboards

July 30, 2025

NeOnc Technologies Signs Definitive Agreement to Acquire AI, 3D, and Quantum Modeling IP Portfolio from Dr. Ishwar K. Puri; Appoints Him to Board of Directors

July 30, 2025

NeOnc Technologies Signs Definitive Agreement for $50 Million Strategic Partnership with Quazar Investment

July 29, 2025

NeOnc Technologies to Participate at the BTIG Virtual Biotechnology Conference

July 28, 2025

CORRECTING and REPLACING - NeOnc Technologies Holdings, Inc.

July 23, 2025

NeOnc Technologies’ Executive Chairman to Be Featured in Live Interview with Kenny Polcari on YouTube.com/@Floorstocks — Today at 11: 00 a.m. ET

July 23, 2025

NeOnc Technologies Executes Sub-License Agreement, Marking Key Milestone Toward Closing $50 Million Strategic Partnership with Quazar Investment

July 22, 2025

NeOnc Technologies Secures Board Approval for $50 Million Strategic Partnership with Quazar Investment

July 10, 2025

NeOnc Technologies Holdings, Inc. Joins Russell Microcap® Index

July 9, 2025

NeOnc Technologies Signs $50 Million Non-Binding Strategic Term Sheet with Quazar Investment to Launch GCC & MENA Expansion and Clinical Trials Platform

July 8, 2025

NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs

June 6, 2025

NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets

April 15, 2025

NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September

April 14, 2025

NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company’s New President

April 10, 2025

NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy

April 8, 2025

NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas

March 31, 2025

NeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer Treatments

March 27, 2025

NEONC Technologies Holdings, Inc. Appoints Renowned Neurosurgeon Dr. Steven L. Giannotta to its Board of Directors

March 24, 2025

NeOnc Technologies Holdings, Inc. Appoints Dr. Victoria Medvec to Board of Directors

March 24, 2025

NEONC Technologies Holdings, Inc. Appoints Dr. Alan Chiang to its Board of Directors

March 24, 2025

NeOnc Technologies Holdings, Inc. Appoints Bader Almonawer to Board of Directors

March 24, 2025

NeOnc Technologies Holdings Announces Effectiveness of Registration Statement and Anticipated Listing Date of Common Stock on Nasdaq Global Market

March 24, 2025

NeOnc Technologies Appointments the Honorable Jimmy Delshad to its Board of Directors

March 24, 2025

NeOnc Technologies Completes $18.5 Million Financing, Advances Phase II Clinical Trials for Enhanced Method of Delivering Novel Therapeutics to the Brain Under FDA Fast-Track Status

June 25, 2024

NeOnc Technologies Wins California Investment Forum’s Breakthrough Medical Technology Achievement Award

May 14, 2024

NeOnc Technologies Invited to Present at California Investment Forum in Anaheim on May 10

May 8, 2024

← Newer news releases

Calls

Decks

The 5 newest of 10 decks. Every deck is listed under its year.